Archford Capital Strategies’s West Pharmaceutical WST Stock Holding History

Archford Capital Strategies’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50	Closed	-$5K	–	685
2018 Q2	$5K	Hold	50	–	–	﹤0.01%	485
2018 Q1	$5K	Buy	+50	New	+$4.68K	﹤0.01%	400
2017 Q2	–	Sell	-50	Closed	-$4K	–	630
2017 Q1	$4K	Hold	50	–	–	﹤0.01%	515
2016 Q4	$4K	Buy	50 +3	+6%	+$236	﹤0.01%	441
2016 Q3	$3K	Sell	47 -47	-50%	-$3.73K	﹤0.01%	497
2016 Q2	$8K	Buy	+94	New	+$6.84K	﹤0.01%	423
2016 Q1	–	Sell	-94	Closed	-$6K	–	613
2015 Q4	$6K	Hold	94	–	–	﹤0.01%	549
2015 Q3	$6K	Buy	94 +47	+100%	+$2.74K	﹤0.01%	431
2015 Q2	$3K	Hold	47	–	–	﹤0.01%	457
2015 Q1	$2.83K	Hold	47	–	–	﹤0.01%	465
2014 Q4	$3K	Hold	47	–	–	﹤0.01%	479
2014 Q3	$2K	Buy	+47	New	+$2K	﹤0.01%	542

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Archford Capital Strategies's WST Position: Q3 2018 in Review

Archford Capital Strategies sold out of West Pharmaceutical (WST) in Q3 2018, closing a stake of 50 shares — an estimated $5K sold.

Archford Capital Strategies first reported a position in WST in Q3 2014 and held it in 12 quarters. The position peaked at $8K in Q2 2016. 354 funds tracked by Wall St. Rank hold WST as of Q3 2018.

Archford Capital Strategies reported no remaining West Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Archford Capital Strategies sold 50 West Pharmaceutical shares in Q3 2018, an estimated $5K.
Archford Capital Strategies first reported a position in West Pharmaceutical in Q3 2014 and held it in 12 quarters.
Archford Capital Strategies's West Pharmaceutical position peaked at $8K in Q2 2016.
354 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2018.

Based on Archford Capital Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.